Obstructive sleep apnea and pregnancy: The effect on perinatal outcomes

Journal of Perinatology

Volumn 32, Issue 6, 2012, Pages 399-406

  Fung, A M ^a   Wilson, D L ^b   Barnes, M ^b   Walker, S P ^a,c  

^a MERCY HOSPITAL FOR WOMEN   (Australia)

^b AUSTIN HEALTH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

CPAP; gestational diabetes; intrauterine growth restriction; preeclampsia

Indexed keywords

ADIPOCYTOKINE;

ADVERSE OUTCOME; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; ELECTROOCULOGRAPHY; HUMAN; INTRAUTERINE GROWTH RETARDATION; MATERNAL HYPERTENSION; PERINATAL PERIOD; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PREDICTIVE VALUE; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREVALENCE; REVIEW; SENSITIVITY AND SPECIFICITY; SLEEP APNEA SYNDROME;

DIABETES, GESTATIONAL; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; OBESITY; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 84861831139     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2012.14     Document Type: Review

References (93)

1. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999; 22: 667-689.
2. Iber C, Ancoli-Israel S, Chesson A, Quan S. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology, and Technical Specification. 1st edn American Academy of Sleep Medicine: Westchester, IL, 2007.
3. Shaw JE, Punjabi NM, Wilding JP, Alberti KG, Zimmet PZ. Sleep-disordered breathing and type 2 diabetes. a report from the international diabetes federation taskforce on epidemiology and prevention. Diabetes Res Clin Pract 2008; 81: 2-12.
4. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-1235.
5. Redline S, Kump K, Tishler PV, Browner I, Ferrette V. Gender differences in sleep disordered breathing in a community-based sample. Am J Respir Crit Care Med 1994; 149: 722-726.
6. Vagiakis E, Kapsimalis F, Lagogianni I, Perraki H, Minaritzoglou A, Alexandropoulou K et al. Gender differences on polysomnographic findings in greek subjects with obstructive sleep apnea syndrome. Sleep Med 2006; 7: 424-430.
7. Maislin G, Pack AI, Kribbs NB, Smith PL, Schwartz R, Kline LR et al. A survey screen for prediction of apnea. Sleep 1995; 18: 158-166.
8. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 1999; 131: 485-491.
9. Friedman M, Wilson MN, Pulver T, Pandya H, Joseph NJ, Lin H et al. Screening for obstructive sleep apnea/hypopnea syndrome: subjective and objective factors. Otolaryngol Head Neck Surg 2010; 142: 531-535.
10. Bliwise DL, Nekich JC, Dement WC. Relative validity of self-reported snoring as a symptom of sleep apnea in a sleep clinic population. Chest 1991; 99: 600-608.
11. Chung F, Yegneswaran B, Liao P, Chung SA, Vairavanathan S, Islan S et al. Validation of the Berlin questionnaire and American society of anesthesiologists checklist as screening tools for obstructive sleep apnea in surgical patients. Anesthesiology 2008; 108: 822-830.
12. Young T, Shahar E, Nieto FJ, Redline S, Newman AB, Gottleib DJ et al. Predictors of sleep-disordered breathing in community-dwelling adults: the sleep heart health study. Arch Intern Med 2002; 162: 893-900.
13. Valencia-Flores M, Orea A, Castano VA, Resendiz M, Rosales M, Rebollar V et al. Prevalence of sleep apnea and electrocardiographic disturbances in morbidly obese patients. Obes Res 2000; 8: 262-269.
14. Bixler EO, Vgontzas AN, Lin H, Have TT, Rein J, Vela-Bueno A et al. Prevalence of sleep-disordered breathing in women. Effects of gender. Am J Respir Crit Care Med 2001; 163: 608-613.
15. Punjabi NM, Caffo BS, Goodwin JL, Gottleib DJ, Newman AB, O'Connor GT et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 2009; 6: e1000132.
16. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Eng J Med 2000; 342: 1378-1384.
17. Teran-Santos J, Jimenez-Gomez A, Cordero-Guevara J. The association between sleep apnea and the risk of traffic accidents. N Engl J Med 1999; 340: 847-851.
18. Lindberg E, Carter N, Gislason T, Janson C. Role of snoring and daytime sleepiness in occupational accidents. Am J Respir Crit Care Med 2001; 164: 2031-2035.
19. Hillman DR, Murphy AS, Antic R, Pezzullo LP. The economic cost of sleep disorders. Sleep 2006; 29: 299-305.
20. Smith ML, Niedermaier ON, Hardy SM, Decker MJ, Strohl KP. Role of hypoxemia in sleep apnea-induced sympathoexcitation. J Autonom Nerv Sys 1996; 56: 184-190.
21. Garcia-Rio F, Racionero MA, Pino JM, Martinez I, Ortuno F, Villasante C et al. Sleep apnea and hypertension. The role of peripheral chemoreceptors and the sympathetic system. Chest 2000; 117: 1417-1425.
22. Cooper VL, Pearson SB, Bowker CM, Elliott MW, Hainsworth R. Interaction of chemoreceptor and baroreceptor reflexes by hypoxia and hypercapnia-a mechanism for promoting hypertension in obstructive sleep apnoea. J Physiol 2005; 568: 677-687.
23. Henley DE, Russell GM, Douthwaite JA, Wood SA, Buchanan F, Gibson R et al. Hypothalamic-pituitary-adrenal axis activation in obstructive sleep apnea: the effect of continuous positive airway pressure therapy. J Clin Endocrinol Metab 2009; 94: 4234-4242.
24. Parlapiano C, Borgia MC, Minni A, Alessandri N, Basal I. Cortisol circadian rhythm and 24-hour Holter arterial pressure in OSAS patients. Endocr Res 2005; 31: 371-374.
25. Carlson JT, Rangemark C, Hedner JA. Attenuated endothelium-dependent vascular relaxation in patients with sleep apnea. J Hypertens 1996; 14: 577-584.
26. Alonso-Fernandez A, Garcia-Rio F, Arias MA, Hernanaz A, de la Pena M, Peirola J et al. Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnea: a randomised trial. Thorax 2009; 64: 581-586.
27. Yokoe T, Minoguchi K, Matsuo H, Yoshino G, Hirano T, Adachi M. Elevated levels of C-reactive protein and interleukin-6 in patient with obstructive sleep apnea are decreased by nasal continuous positive airway pressure. Circulation 2003; 107: 1129-1134.
28. Steiropoulos P, Kotsianidis I, Nena E, Tsara V, Gounari E, Hatzizisi O et al. Long-term effect of continuous positive airway pressure therapy on inflammation markers of patients with obstructive sleep apnea syndrome. Sleep 2009; 32: 537-543.
29. Shamsuzzaman AS, Winnicki M, Lanfranchi P, Wolk R, Kara T, Accurso V et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002; 105: 2462-2464.
30. Tokuda F, Sando Y, Matsui H, Koike H, Yokoyama T. Serum levels of adipocytokines, adiponectin and leptin in patients with obstructive sleep apnea syndrome. Inter Med 2008; 47: 1843-1849.
31. Ip MS, Lam KS, Ho C, Tsang KW, Lam W. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 2000; 118: 580-586.
32. Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A et al. Plasma leptin and the risk of cardiovascular disease in the west of scotland coronary prevention study (WOSCOPS). Circulation 2001; 104: 3052-3056.
33. Lam JC, Xu A, Tam S, Khong P, Yao T, Lam DC et al. Hypoadiponectinemia is related to sympathetic activation and severity of obstructive sleep apnea. Sleep 2008; 31: 1721-1727.
34. Nakagawa Y, Kishida K, Kihara S, Sonoda M, Hirata A, Yasui A et al. Nocturnal reduction in circulating adiponectin concentrations related to hypoxic stress in severe obstructive sleep apnea-hypopnea syndrome. Am J Physiol Endcrinol Metab 2008; 294: E778-E784.
35. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046-1053.
36. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Nieto J et al. Sleep-disordered breathing and cardiovascular disease. Cross-sectional results of the sleep heart health study. Am J Respir Crit Care Méd 2001; 163: 19-25.
37. Meslier N, Gagnadoux F, Giraud P, Person C, Ouksel H, Urban T et al. Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome. Eur Respir J 2003; 22: 156-160.
38. Theorell-Haglow J, Berne C, Janson C, Lindberg E. The role of obstructive sleep apnea in metabolic syndrome: A population-based study in women. Sleep Med 2011; 12: 329-334.
39. Parish JM, Adam T, Facchiano L. Relationship of metabolic syndrome and obstructive sleep apnea. J Clin Sleep Med 2007; 3: 467-472.
40. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004; 25: 735-741.
41. Maasilta P, Bachour A, Teramo K, Pólo O, Laitinen LA. Sleep-related disordered breathing during pregnancy in obese women. Chest 2001; 120: 1448-1454.
42. Oksenberg A, Khamaysi I, Silverberg DS, Tarasiuk A. Association of body position with severity of apneic events in patients with severe nonpositional obstructive sleep apnea. Chest 2000; 118: 1018-1024.
43. Weinberger SE, Weiss ST, Cohen WR, Weiss JW, Johnson TS. State of the art: pregnancy and the lung. Am Rev Respir Dis 1980; 121: 559-581.
44. Bende M, Gredmark T. Nasal stuffiness during pregnancy. Laryngoscope 1999; 109: 1108-1110.
45. Contreras G, Gutierrez M, Beroiza T, Fantin A, Oddo H, Villarroel L et al. Ventilatory drive and respiratory muscle function in pregnancy. Am Rev Respir Dis 1991; 144: 837-841.
46. Loube DJ, Poceta JS, Morales MC, Peacock MD, Mitler MM. Self-reported snoring in pregnancy. Association with fetal outcome. Chest 1996; 109: 885-889.
47. Franklin KA, Holmgren PA, Jonsson F, Poromaa N, Stenlund H, Svanborg E. Snoring, pregnancy-induced hypertension, and growth retardation of the fetus. Chest 2000; 117: 137-141.
48. Pien GW, Fife D, Pack AI, Nkwuo E, Schwab RJ. Changes in symptoms of sleep-disordered breathing during pregnancy. Sleep 2005; 28: 1299-1305.
49. Izci B, Vennelle M, Liston WA, Dundas KC, Calder AA, Douglas NJ. Sleep disordered breathing and upper airway size in pregnancy and postpartum. Eur Respir J 2006; 27: 321-327.
50. Edwards N, Blyton DM, Hennessy A, Sullivan CE. Severity of sleep-disordered breathing improves following parturition. Sleep 2005; 28: 737-741.
51. Izci B, Martin SE, Dundas KC, Liston WA, Calder AA, Douglas NJ. Sleep complaints: snoring and daytime sleepiness in pregnant and pre-eclamptic women. Sleep Med 6; 2005: 163-169.
52. Perez-Chada D, Videla AJ, O'Flaherty ME, Majul C, Catalini AM, Caballer CA et al. Snoring, witnessed sleep apnoeas and pregnancy-induced hypertension. Acta Obst Gynecol 2007; 86: 788-792.
53. Bourjeily G, Raker CA, Chalhoub M, Miller MA. Pregnancy and fetal outcomes of symptoms of sleep-disordered breathing. Eur Respir J 2010; 36: 849-855.
54. Louis JM, Auckley D, Sokol RJ, Mercer BM. Maternal and neonatal morbidities associated with obstructive sleep apnea complicating pregnancy. Am J Obstet Gynecol 2010; 202: 261.e1-5.
55. Champagne K, Schwartzman K, Opatrny L, Barriga P, Morin L, Mallozzi A et al. Obstructive sleep apnoea and its association with gestational hypertension. Eur Respir J 2009; 33: 559-565.
56. Reid J, Skomro R, Cotton D, Ward H, Olatunbosun F, Gjevre J et al. Pregnant women with gestational hypertension may have a higher frequency of sleep disordered breathing. Sleep 2011; 34: 1033-1038.
57. Olivarez SA, Ferres M, Antony K, Mattewal A, Maheshwari B, Sangi-Haghpeykar H et al. Obstructive sleep apnea screening in pregnancy, perinatal outcomes, and impact of maternal obesity. Am J Perinatol 2011; 28: 651-658.
58. Qiu C, Enquobahrie D, Frederick IO, Abetew D, Williams MA. Glucose intolerance and gestational diabetes risk in relation to sleep duration and snoring during pregnancy: a pilot study. BMC Women's Health 2010; 10: 17.
59. Reutrakul S, Zaidi N, Wroblewski K, Kay HH, Ismail M, Ehrmann DA et al. Sleep disturbances and their relationship to glucose tolerance in pregnancy. Diabetes Care 2011; 34: 2454-2457.
60. Kristensen J, Vestergaard M, Wisborg K, Kesmodel U, Secher NJ. Pre-pregnancy weight and the risk of stillbirth and neonatal death. BJOG 2005; 112: 403-408.
61. Cnattingius S, Bergstrom R, Lipworth L, Kramer MS. Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med 1998; 338: 147-152.
62. Flenady V, Koopmans L, Middleton P, Froen JF, Smith GC, Gibbons K et al. Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. Lancet 2011; 377: 1331-1340.
63. Chu SY, Kim SY, Lau J, Schmid CH, Dietz PM, Callaghan WM et al. Maternal obesity and risk of stillbirth: a metaanalysis. Am J Obstet Gynecol 2007; 197: 223-228.
64. Arendas K, Qiu Q, Gruslin A. Obesity in pregnancy: pre-conceptional to Postpartum consequences. J Obstet Gynaecol Can 2008; 30: 477-488.
65. Hedman C, Pohjasvaara T, Tolonen U, Suhonen-Malm AS, Myllyla VV. Effects of pregnancy on mothers' sleep. Sleep Méd 2002; 3: 37-42.
66. Sahin FK, Koken G, Cosar E, Saylan F, Fidan F, Yilmazer M et al. Obstructive sleep apnea in pregnancy and fetal outcome. Int J Gynecol and Obstet 2008; 100: 141-146.
67. Olivarez SA, Maheshwari B, McCarthy M, Zacharias N, Van den Veyver I, Casturi L et al. Prospective trial on obstructive sleep apnea in pregnancy and fetal heart rate monitoring. Am J Obstet Gynecol 2010; 202: e1-e7.
68. Schwab RJ, Pack AI, Gupta KB, Metzger LJ, Oh E, Getsy JE et al. Upper airway and soft tissue structural changes induced by cpap in normal subjects. Am J Respir Crit Care Med 1996; 154: 1106-1116.
69. Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1981; 1: 862-865.
70. Loredo JS, Ancoli-Israel S, Dimsdale JE. Effect of continuous positive airway pressure vs placebo continuous airway pressure on sleep quality in obstructive sleep apnea. Chest 1999; 116: 1545-1549.
71. Faccenda JF, Mackay TW, Boon NA, Douglas NJ. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001; 163: 344-348.
72. Mazza S, Pepin J-L, Naegele B, Rauch E, Deschaux C, Ficheux P et al. Driving ability in sleep apnoea patients before and after CPAP treatment: evaluation on a road safety platform. Eur Resp J 2006; 28: 1020-1028.
73. Cassel W, Ploch T, Becker C, Dugnes D, Peter JH, von Wichert P. Risk of traffic accidents in patients with sleep-disordered breathing: reduction with nasal CPAP. Eur Respir J 1996; 9: 2606-2611.
74. Ziegler MG, Mills PJ, Loredo JS, Ancoli-Israel S, Dimsdale J. Effect of continuous positive airway pressure and placebo treatment on sympathetic nervous activity in patients with obstructive sleep apnea. Chest 2001; 120: 887-893.
75. Logan AG, Tkacova R, Perlikowski SM, Leung RS, Tisler A, Floras JS et al. Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur Respir J 2003; 21: 241-247.
76. Middleton S, Vermeulen W, Byth K, Sullivan CE, Middleton PG. Treatment of obstructive sleep apnoea in Samoa progressively reduces daytime blood pressure over 6 months. Respirology 2009; 14: 404-410.
77. Barbe F, Duran-Cantolla J, Capote F, de la Pena M, Chiner E, Masa JF et al. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 2010; 181: 718-726.
78. Campos-Rodriguez F, Perez-Ronchel J, Grilo-Reina A, Lima-Alvirez J, Benitez MA, Aimeida-Gonzalez C. Long-term effect of continuous positive airway pressure on BP in patients with hypertension and sleep apnea. Chest 2007; 132: 1847-1852.
79. Alajmi M, Mulgrew AT, Fox J, Davidson W, Schulzer M, Mak E et al. Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung 2007; 185: 67-72.
80. Smurra M, Philip P, Taillard J, Guilleminault C, Bioulac B, Gin G. CPAP treatment does not affect glucose-insulin metabolism in sleep apneic patients. Sleep Med 2001; 2: 207-213.
81. Lam JC, Lam B, Yao TJ, Lai AY, Ooi CG, Tam S et al. A randomised controlled trial of nasal continuous airway pressure on insulin sensitivity in obstructive sleep apnea. Eur Respir J 2010; 35: 138-145.
82. Oktay B, Akbal E, Firat H, Ardic S, Kizilgun M. CPAP treatment in the coexistence of obstructive sleep apnea syndrome and metabolic syndrome, results of one year follow up. Acta Clin Belg 2009; 64: 329-334.
83. Cuhadaroglu C, Utkusavas A, Ozturk L, Salman S, Ece T. Effects of nasal CPAP treatment on insulin Resistance, lipid profile and plasma leptin in sleep apnea. Lung 2009; 187: 75-81.
84. Hecht L, Mohler R, Meyer G. Effects of CPAP-respiration on markers of glucose metabolism in patients with obstructive sleep apnoea syndrome: a systematic review and meta-analysis. Ger Med Sci 2011; 9: Doc20.
85. Drummond M, Winck JC, Guimaraes JT, Santos AC, Almeida J, Marques JA. Autoadjusting-CPAP effect on serum Leptin concentrations in Obstructive Sleep Apnoea patients. BMC Pulm Med 2008; 8: 21.
86. de Lima AM, Franco CM, de Castro CM, de Andrade Bezerra A, Ataide L, Halpern A. Effects of nasal continuous positive airway pressure treatment on oxidative stress and adiponectin levels in obese patients with obstructive sleep apnea. Respiration 2010; 79: 370-376.
87. Zhang XL, Yin KS, Li C, Jia E, Li Y, Gao Z. Effect of continuous positive airway pressure treatment on serum adiponectin level and mean arterial pressure in male patients with obstructive sleep apnea syndrome. Chin Med J 2007; 120: 1477-1481.
88. Guilleminault C, Kreutzer M, Chang JL. Pregnancy, sleep disordered breathing and treatment with nasal continuous positive airway pressure. Sleep Med 2004; 5: 43-51.
89. Wolkove N, Baltzan M, Kamel H, Dabrusin R, Palayew M. Long-term compliance with continuous positive airway pressure in patients with obstructive sleep apnea. Can Respir J 2008; 15: 365-369.
90. Sin DD, Mayers I, Man GC, Pawluk L. Long-term compliance rates to continuous positive airway pressure in obstructive sleep apnea. A population-based study. Chest 2002; 121: 430-435.
91. Edwards N, Blyton DM, Kirjavainen T, Kesby GJ, Sullivan CE. Nasal continuous positive airway pressure reduces sleep-induced blood pressure increments in preeclampsia. Am J Respir Crit Care Med 2000; 162: 252-257.
92. Guilleminault C, Palombini L, Poyares D, Takaoka S, Huynh NT, El-Sayed Y. Pre-eclampsia and nasal CPAP: Part 1. Early intervention with nasal CPAP in pregnant women with risk-factors for pre-eclampsia: Preliminary findings. Sleep Med 2007; 9: 9-14.
93. Poyares D, Guilleminault C, Hachul H, Fujita L, Takaoka S, Tufik S et al. Pre-eclampsia and nasal CPAP: Part 2. Hypertension during pregnancy, chronic snoring, and early nasal CPAP intervention. Sleep Med 2007; 9: 15-21.